Impact of obesity on immune-related adverse events and tyrosine kinase inhibitor side effects in patients with metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Alharbi, Malak
Tariq, Muhammad Junaid
Jatwani, Karan
George, Saby
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY USA
[2] Roswell Pk Canc Inst, Buffalo, IL USA
[3] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4560
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors
    Silberg, Matteo
    Krabbe, Laura-Maria
    Boegemann, Martin
    Schrader, Andres Jan
    Tully, Karl
    Schlack, Katrin
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [42] Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinoma
    Elghawy, Omar
    Barsouk, Adam
    Patel, Reema
    Reed-Guy, Lauren
    Wang, John S.
    Xu, Jessica
    Yang, Austin
    Sussman, Jonathan
    Kaur, Varinder
    IMMUNOTHERAPY, 2024,
  • [43] Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
    Ng, Kennedy Yao Yi
    Tan, Sze Huey
    Tan, Jack Jie En
    Tay, Desiree Shu Hui
    Lee, Ailica Wan Xin
    Ang, Andrea Jing Shi
    Wong, Lawrence Wen Jun
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    LIVER CANCER, 2022, 11 (01) : 9 - 21
  • [44] ASSOCIATION OF IMMUNE RELATED ADVERSE EVENTS WITH THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN METASTATIC RENAL CELL CARCINOMA
    Bushunow, Vasilii
    Appleman, Leonard
    Thomas, Roby
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A112 - A113
  • [45] Outcomes in PD-1/PD-L1 responders who discontinued therapy for immune-related adverse events (irAEs): analysis of nine patients with metastatic renal cell carcinoma (mRCC)
    Martini, Dylan
    Brandao, Raphael
    Hamieh, Lana
    Norton, Craig
    Mullane, Stephanie
    Walsh, Meghara
    Van Allen, Eliezer
    Mckay, Rana
    Harshman, Lauren
    Choueiri, Toni
    BJU INTERNATIONAL, 2016, 118 : 10 - 11
  • [46] Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
    Isik, Busra
    Alexander, Mariam P.
    Manohar, Sandhya
    Vaughan, Lisa
    Kottschade, Lisa
    Markovic, Svetomir
    Lieske, John
    Kukla, Aleksandra
    Leung, Nelson
    Herrmann, Sandra M.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 1022 - 1031
  • [47] Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor
    Nafissi, Nellie N.
    Karlin, Nina
    Pittelkow, Mark R.
    Dicaudo, David J.
    Mangold, Aaron R.
    ANTI-CANCER DRUGS, 2021, 32 (04) : 474 - 475
  • [48] Evaluation of immune-related adverse events in patients treated with sequential immunotherapy and tyrosine kinase inhibitor treatment in non-small cell lung cancer.
    Baroz, Angel Ray
    Mambetsariev, Isa
    Fricke, Jeremy
    Pharaon, Rebecca
    Zhao, Dan
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events
    Ivanova, E.
    Asadullina, D.
    Rakhimov, R.
    Izmailov, A.
    Izmailov, Al.
    Gilyazova, G.
    Galimov, Sh.
    Pavlov, V.
    Khusnutdinova, E.
    Gilyazova, I.
    NON-CODING RNA RESEARCH, 2022, 7 (03): : 159 - 163
  • [50] Salvage lenvatinib/everolimus (LE) combination therapy after immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) for metastatic renal cell carcinoma (mRCC)
    Khorasanchi, Adam
    Kwok, Christopher
    Psutka, Sarah P.
    Hinkley, Megan
    Dason, Shawn
    Yang, Yuanquan
    Verschraegen, Claire F.
    Gross, Evan
    Orcutt, Delaney
    Yin, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345